Brief: Pasithea Therapeutics Announces Completion Of GMP Manufacturing For Pas-004
29/06/2023 14:34
June 29 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS ANNOUNCES COMPLETION OF GMP
MANUFACTURING
FOR PAS-004
* PASITHEA THERAPEUTICS - EXPECTS TO FILE INVESTIGATIONAL
NEW
DRUG APPLICATION FOR PAS-004 WITH U.S. FDA IN SECOND HALF OF
2023
* PASITHEA THERAPEUTICS CORP - INTENDS TO UTILIZE THIS
SUPPLY OF
PAS-004 FOR ITS UPCOMING PHASE I CLINICAL TRIAL
Source text for Eikon: ID:nGNX7dN7Vl
Further company coverage: KTTA.O
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement